These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28509626)

  • 1. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use.
    L'Hermite M
    Climacteric; 2017 Jun; 20(3):205-211. PubMed ID: 28509626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioidentical hormone therapy: a review of the evidence.
    Cirigliano M
    J Womens Health (Larchmt); 2007 Jun; 16(5):600-31. PubMed ID: 17627398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review.
    Files J; Kling JM
    Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776
    [No Abstract]   [Full Text] [Related]  

  • 7. Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6.
    Obstet Gynecol; 2023 Nov; 142(5):1266-1273. PubMed ID: 37856860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioidentical hormones.
    Stanczyk FZ; Matharu H; Winer SA
    Climacteric; 2021 Feb; 24(1):38-45. PubMed ID: 33403887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the concerns about custom-compounded "bioidentical" hormone therapy?
    Pinkerton JV
    Menopause; 2014 Dec; 21(12):1298-300. PubMed ID: 25387347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and effectiveness of compounded bioidentical hormone therapy: a case series.
    Davis R; Batur P; Thacker HL
    J Womens Health (Larchmt); 2014 Aug; 23(8):642-8. PubMed ID: 25111856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compounded or confused? Bioidentical hormones and menopausal health.
    Huntley AL
    Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounded bioidentical menopausal hormone therapy.
    ;
    Fertil Steril; 2012 Aug; 98(2):308-12. PubMed ID: 22831824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Committee opinion No. 532: compounded bioidentical menopausal hormone therapy.
    Committee on Gynecologic Practice and the American Society for Reproductive Medicine Practice Committee
    Obstet Gynecol; 2012 Aug; 120(2 Pt 1):411-5. PubMed ID: 22825109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioidentical hormones for menopausal therapy.
    Sites CK
    Womens Health (Lond); 2008 Mar; 4(2):163-71. PubMed ID: 19072518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioidentical hormones for menopausal hormone therapy: variation on a theme.
    Fugh-Berman A; Bythrow J
    J Gen Intern Med; 2007 Jul; 22(7):1030-4. PubMed ID: 17549577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.